Virtual: Identifying and Establishing Biomarkers for Complex Rare Diseases
Time: 1:30 pm
day: Post-Conference Discussion Day - Track B
Details:
- Validating biomarkers to contribute to defining clinical endpoints
- Balancing standard biomarkers and novel ones – time versus effectiveness
- Predicting real-time efficacy with the patient journey at the centre
